C. A. Sanhueza et al. / Tetrahedron: Asymmetry 19 (2008) 258–264
263
69.6 (d, C-4), 69.0 (d, C-2). 63.2 (t, C-6), 20.7 (q), 20.5 (q),
11.3 (q); UV (CH3CN) kmax 245 nm; CD (CH3CN) kext nm
(De) 251 (15.1), 234 (À6.8).
C31H28Br2O9S: C, 50.56; H, 3.83; S, 4.35. Found: C,
50.54; H, 3.98; S, 4.34.
4.8. Isopropyl 2,3-di-O-acetyl-4,6-bis-O-(4-bromo-benzoyl)-
1-thio-b-D-glucopyranoside 6b
4.5. Ethyl 2,3-di-O-acetyl-4,6-bis-O-(4-bromobenzoyl)-
1-thio-b-D-glucopyranoside 3b
TLC Rf = 0.40 (n-hexane/EtOAc 3:1); [a]D = À6.3 (c 0.7,
CHCl3); HRMS (FAB): Calcd for C27H28O9NaSBr2
TLC Rf = 0.42 (n-hexane/EtOAc 3:1); [a]D = +1.7 (c 1.0,
1
([M+Na]+): 708.9718, found: 708.9684; H NMR (CDCl3)
CHCl3); HRMS (FAB): Calcd for C26H26O9 79Br2SCs
1
([M+Cs]+): 804.8719, found: 804.8711; H NMR (CDCl3)
d 7.82–7.77 (m, 4H), 7.56–7.50 (m, 4H), 5.45 (dd, J = 9.4
and 9.4 Hz, H-3), 5.37 (dd, J = 9.7 and 9.7 Hz, H-4), 5.08
(dd, J = 9.4 and 9.4 Hz, H-2), 4.69 (d, J = 10.1 Hz, H-1),
4.51 (dd, J = 3.2 and 12.1 Hz, H-6S), 4.38 (dd, J = 5.6
and 12.1 Hz, H-6R), 3.98 (ddd, J = 3.2, 5.6 and 9.3 Hz,
H-5), 3.17 (m, 1H), 2.07 (s, 3H), 1.90 (s, 3H), 1.29 (d,
J = 6.7 Hz, 3H), 1.27 (d, J = 6.7 Hz, 3H); 13C NMR
(CDCl3) d 170.1 (s), 169.4 (s), 165.3 (s), 164.4 (s), 132.0-
127.5, 83.5 (d, C-1), 75.6 (d, C-5), 73.5(d, C-3), 70.2 (d,
C-2), 69.9 (d, C-4), 63.5 (t, C-6), 35.7 (d), 24.0 (q), 23.8
(q), 20.7 (q), 20.5 (q); UV (CH3CN) kmax 245 nm; CD
(CH3CN) kext nm (De) 251 (13.1), 233 (À6.5); Anal. Calcd
for C27H28Br2O9S: C, 47.11; H, 4.10; S, 4.66. Found: C,
47.11; H, 4.18; S, 4.46.
d 7.82–7.77 (m, 4H), 7.55–7.51 (m, 4H), 5.44 (dd, J = 9.2
and 9.2 Hz, H-3), 5.39 (dd, J = 9.5 and 9.5 Hz, H-4), 5.12
(dd, J = 9.5 and 9.5 Hz, H-2), 4.61 (d, J = 10.0 Hz, H-1),
4.52 (dd, J = 3.3 and 12.2 Hz, H-6S), 4.39 (dd, J = 5.1
and 12.2 Hz, H-6R), 3.98 (ddd, J = 3.3, 5.1 and 8.9 Hz,
H-5), 2.78–2.63 (m, 2H), 2.07 (s, 3H), 1.90 (s, 3H), 1.26
(dd, J = 7.4 and 7.4 Hz, 3H); 13C NMR (CDCl3) d 170.1
(s), 169.4 (s), 165.3 (s), 164.4 (s), 131.1-127.5, 83.7 (d, C-
1), 75.7 (d, C-5), 73.5(d, C-3), 69.9 (d, C-2), 69.8 (d, C-4),
63.4 (t, C-6), 24.2 (t), 20.7 (q), 20.5 (q), 14.9 (q); UV
(CH3CN) kmax 245 nm; CD (CH3CN) kext nm (De) 251
(14.6), 234 (À7.0).
4.6. Propyl 2,3-di-O-acetyl-4,6-bis-O-(4-bromobenzoyl)-1-
thio-b-D-glucopyranoside 4b
4.9. Cyclohexyl 2,3-di-O-acetyl-4,6-bis-O-(4-bromobenzo-
yl)-1-thio-b-D-glucopyranoside 7b
TLC Rf = 0.47 (n-hexane/EtOAc 3:1); [a]D = +1.9 (c 0.1,
TLC Rf = 0.45 (n-hexane/EtOAc 3:1); [a]D = +3.9 (c 0.9,
CHCl3); HRMS (FAB): Calcd for C27H28O9NaS79Br81Br
CHCl3); HRMS (FAB): Calcd for C30H32O9NaS81Br2
1
([M+Na]+): 710.9698, found: 710.9704; H NMR (CDCl3)
1
([M+Na]+): 752.9991, found: 752.9957; H NMR (CDCl3)
d 7.82–7.77 (m, 4H), 7.56–7.51 (m, 4H), 5.44 (dd, J = 9.2
and 9.2 Hz, H-3), 5.38 (dd, J = 9.5 and 9.5 Hz, H-4), 5.11
(dd, J = 9.5 and 9.5 Hz, H-2), 4.59 (d, J = 10.0 Hz, H-1),
4.52 (dd, J = 3.2 and 12.2 Hz, H-6S), 4.39 (dd, J = 5.2
and 12.2 Hz, H-6R), 3.97 (ddd, J = 3.2, 5.2 and 9.0 Hz,
H-5), 2.75–2.57 (m, 2H), 2.07 (s, 3H), 1.90 (s, 3H), 1.67–
1.57 (m, 2H), 0.94 (dd, J = 7.3 and 7.3 Hz, 3H); 13C
NMR (CDCl3) d 170.1 (s), 169.4 (s), 165.3 (s), 164.4 (s),
131.9–127.5, 83.9 (d, C-1), 75.7 (d, C-5), 73.5(d, C-3),
69.9 (d, C-2), 69.8 (d, C-4), 63.3 (t, C-6), 32.2 (t), 23.2 (t),
20.7 (q), 20.5 (q), 13.4 (q); UV (CH3CN) kmax 245 nm;
CD (CH3CN) kext nm (De) 251 (13.8), 234 (À6.3); Anal.
Calcd for C27H28Br2O9S: C, 47.11; H, 4.10; S, 4.66. Found:
C, 47.42; H, 3.84; S, 4.32.
d 7.82–7.77 (m, 4H), 7.55–7.50 (m, 4H), 5.44 (dd, J = 9.4
and 9.4 Hz, H-3), 5.35 (dd, J = 9.7 and 9.7 Hz, H-4), 5.07
(dd, J = 9.5 and 9.5 Hz, H-2), 4.70 (d, J = 10.1 Hz, H-1),
4.50 (dd, J = 3.2 and 12.2 Hz, H-6S), 4.39 (dd, J = 5.8
and 12.2 Hz, H-6R), 3.98 (ddd, J = 3.2, 5.8 and 9.4 Hz,
H-5), 2.90 (m, 1H), 2.06 (s, 3H), 2.03–1.91 (m, 2H), 1.89
(s, 3H), 1.69–1.56 (m, 4H), 1.45–1.13 (m, 4H); 13C NMR
(CDCl3) d 170.0 (s), 169.3 (s), 165.2 (s), 164.4 (s), 131.9–
127.5, 83.3 (d, C-1), 75.6 (d, C-5), 73.5(d, C-3), 70.2 (d,
C-2), 69.9 (d, C-4), 63.5 (t, C-6), 43.9 (d), 34.1 (t), 33.9
(t), 26.0 (t), 25.9 (t), 25.5 (t), 20.7 (q), 20.5 (q); UV
(CH3CN) kmax 245 nm; CD (CH3CN) kext nm (De) 251
(11.0), 233 (À4.8); Anal. Calcd for C30H32Br2O9S: C,
49.46; H, 4.43; S, 4.40. Found: C, 49.44; H, 4.60; S, 4.43.
4.7. Benzyl 2,3-di-O-acetyl-4,6-bis-O-(4-bromobenzoyl)-1-
thio-b-D-glucopyranoside 5b
4.10. tert-Butyl 2,3-di-O-acetyl-4,6-bis-O-(4-bromo-benzo-
yl)-1-thio-b-D-glucopyranoside 8b
TLC Rf = 0.38 (n-hexane/EtOAc 3:1); [a]D = À49.8 (c 0.8,
CHCl3); HRMS (FAB): Calcd for C31H28O9NaSBr2
([M+Na]+): 756.9718, found: 756.9733.; 1H NMR (CDCl3)
d 7.86–7.76 (m, 4H), 7.56–7.52 (m, 4H), 7.52–7.26 (m, 5H),
5.38–5.35 (m, H-3 and H-4), 5.15 (dd, J = 9.6 and 9.6 Hz,
H-2), 4.52 (dd, J = 3.2 and 12.2 Hz, H-6S), 4.40 (dd,
J = 5.0 and 12.2 Hz, H-6R), 4.39 (d, J = 9.9 Hz, H-1),
3.93 (d, J = 13.0 Hz, 1H), 3.87 (m, H-5), 3.83 (d,
J = 13.0 Hz, 1H), 2.03 (s, 3H), 1.89 (s, 3H); 13C NMR
(CDCl3) d 170.0 (s), 169.4 (s), 165.3 (s), 164.4 (s), 136.7–
127.4, 82.1 (d, C-1), 75.7 (d, C-5), 73.4 (d, C-3), 69.8 (d,
C-4), 69.8 (d, C-2), 63.4 (t, C-6), 33.8 (t), 20.7 (q), 20.5
(q); UV (CH3CN) kmax 245 nm; CD (CH3CN) kext nm
(De) 252 (12.9), 234 (À8.5), 211 (À8.9); Anal. Calcd for
TLC Rf = 0.42 (n-hexane/EtOAc 3:1); [a]D = À13.7 (c 0.6,
CHCl3); HRMS (FAB): Calcd for C28H30O9NaSBr2
1
([M+Na]+): 722.9875, found: 722.9841; H NMR (CDCl3)
d 7.81–7.78 (m, 4H), 7.57–7.52 (m, 4H), 5.48 (dd, J = 9.4
and 9.4 Hz, H-3), 5.32 (dd, J = 9.5 and 9.5 Hz, H-4), 5.03
(dd, J = 9.7 and 9.7 Hz, H-2), 4.74 (d, J = 10.2 Hz, H-1),
4.49 (dd, J = 2.9 and 12.2 Hz, H-6S), 4.37 (dd, J = 6.6
and 12.2 Hz, H-6R), 4.01 (ddd, J = 2.9, 6.6 and 9.7 Hz,
H-5), 2.05 (s, 3H), 1.90 (s, 3H), 1.35 (s, 9H); 13C NMR
(CDCl3) d 170.1 (s), 169.3 (s), 165.3 (s), 164.5 (s), 132.0–
127.5, 82.5 (d, C-1), 75.6 (d, C-5), 73.6 (d, C-3), 70.2 (d,
C-2), 69.9 (d, C-4), 63.8 (t, C-6), 44.3 (s), 31.4 (q  3Cs),
20.8 (q), 20.5 (q); UV (CH3CN) kmax 245 nm; CD
(CH3CN) kext nm (De) 252 (9.2), 233 (À5.5); Anal. Calcd